Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
Ranitidine hydrochloride
Aspen Pharmacare Australia Pty Ltd
Medicine Registered
1 ZANTAC ® TABLETS, DISPERSIBLE TABLETS, EFFERVESCENT TABLETS, SYRUP AND INJECTION PRODUCT INFORMATION NAME OF THE MEDICINE: Ranitidine hydrochloride STRUCTURE: O N CH 3 CH 3 S N H N CHNO 2 H CH 3 . HCl CAS NUMBER: 66357-59-3 MOLECULAR FORMULA: C 13 H 22 N 4 O 3 S.HCl MOLECULAR WEIGHT: 350.9 CHEMICAL NAME: N-(2-(((5-((Dimethylamino)methyl)-2-furan-yl)methyl)thio)ethyl)N'-methyl-2-nitro- 1, 1-ethenediamine, hydrochloride. DESCRIPTION: Ranitidine hydrochloride is a histamine H 2 - receptor antagonist. It is an aminoalkyl-substituted furan and is structurally different from cimetidine lacking the imidazole ring and the cyanoguanidine group. Ranitidine hydrochloride is a white to pale yellow granular solid with a melting point of about 140°C. It is freely soluble in water, with a partition co-efficient between n- octanol and water log P = 0.20. It has a slightly bitter taste and sulfurlike odour. Zantac Tablets, Dispersible Tablets, Effervescent Tablets, Syrup and Injection contain the active ingredient ranitidine hydrochloride. Zantac 150 mg Tablets contain the following excipients: magnesium stearate, microcrystalline cellulose, hypromellose, titanium dioxide and glycerol triacetate. Zantac 300 mg Tablets contain the following excipients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, hypromellose, titanium dioxide and glycerol triacetate. Zantac 150 mg Dispersible Tablets contain the following excipients: croscarmellose sodium, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, Peppermint flavour 17.02.0608, saccharin sodium, titan Izlasiet visu dokumentu